G6B-16393-21336
3 vaccinations
2 coded responses
8 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Dose 1 — Pfizer-BioNTech
-
2021-05-21
Dose 2 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
- 2021-06-15
- 2021-06-18
- 2021-06-25
- 2021-07-04
- 2021-08-20
-
2021-11-19
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold - tested for Covid and none detectedMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Dose 3 — Moderna
- 2022-06-09
-
2022-12-09
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Many colds/sinus infectionsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-21 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: Cold - tested for Covid and none detected
Release 12 — 12 months, dose 3
Symptoms: Many colds/sinus infections
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release